Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal Magnesium Sulphate for Fetal Neuroprotection in Preterm Birth
NCT07524972Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- May 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cerebral palsy (CP) comparing Magnesium Sulphate with Placebo (2 arms). Primary endpoint: Combined incidence of death or cerebral palsy at 6 months. Started May 2026; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT07524972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07524972.